Not logged in.png)
Share.png)
SaveShare Save Safety and efficacy of pemetrexed for patients with non-small cell lung cancer in the setting of renal impairment: a retrospective study
Shima, Yusuke; Yoshida, Hironori; Suminaga, Keiichiro; Yoshida, Hiroshi; Hashimoto, Kentaro; Ogimoto, Tatsuya; Hosoya, Kazutaka; Ajimizu, Hitomi; Funazo, Tomoko; Nomizo, Takashi; Ozasa, Hiroaki; Hirai, Toyohiro Share Save Performance status improvement and advances in systemic treatment after brain metastases resection: a retrospective single-center cohort study of non-small cell lung cancer patientsHosoya, Kazutaka; Ozasa, Hiroaki; Tanji, Masahiro; Yoshida, Hiroshi; Ajimizu, Hitomi; Tsuji, Takahiro; Yoshida, Hironori; Terada, Yukinori; Sano, Noritaka; Mineharu, Yohei; Miyamoto, Susumu; Hirai, Toyohiro; Arakawa, Yoshiki Share Save Soluble immune checkpoint factors reflect exhaustion of antitumor immunity and response to PD-1 blockadeHayashi, Hidetoshi; Chamoto, Kenji; Hatae, Ryusuke; Kurosaki, Takashi; Togashi, Yosuke; Fukuoka, Kazuya; Coto, Megumi; Chiba, Yasutaka; Tomida, Shuta; Ota, Takayo; Haratani, Koji; Takahama, Takayuki; Tanizaki, Junko; Yoshida, Takeshi; Iwasa, Tsutomu; Tanaka, Kaoru; Takeda, Masayuki; Hirano, Tomoko; Yoshida, Hironori; Ozasa, Hiroaki; Sakamori, Yuichi; Sakai, Kazuko; Higuchi, Keiko; Uga, Hitoshi; Suminaka, Chihiro; Hirai, Toyohiro; Nishio, Kazuto; Nakagawa, Kazuhiko; Honjo, Tasuku Share Save Enhanced microglial phagocytosis of metastatic brain tumor cells with Cd24a/Cd47 depletionTsuji, Takahiro; Hirose, Haruka; Shindo, Mariko; Hartantyo, Rahadian Yudo; Saito, Yutaro; Hosoya, Kazutaka; Yoshida, Hiroshi; Kato, Daisuke; Yoshizawa, Akihiko; Arakawa, Yoshiki; Ozasa, Hiroaki; Hirai, Toyohiro; Wake, Hiroaki Share Save Establishment of intratumor heterogeneity using patient derived lung cancer cellsFunazo, Tomoko; Ozasa, Hiroaki; Tsuji, Takahiro; Shima, Yusuke; Suminaga, Keiichiro; Hashimoto, Kentaro; Yoshida, Hiroshi; Ogimoto, Tatsuya; Hosoya, Kazutaka; Ajimizu, Hitomi; Nomizo, Takashi; Yoshida, Hironori; Hirai, Toyohiro Share Save Share Save Share Save Combination Therapy with EGFR Tyrosine Kinase Inhibitors and TEAD Inhibitor Increases Tumor Suppression Effects in EGFR Mutation-positive Lung CancerOgimoto, Tatsuya; Ozasa, Hiroaki; Tsuji, Takahiro; Funazo, Tomoko; Yamazoe, Masatoshi; Hashimoto, Kentaro; Yoshida, Hiroshi; Hosoya, Kazutaka; Ajimizu, Hitomi; Nomizo, Takashi; Yoshida, Hironori; Hamaji, Masatsugu; Menju, Toshi; Yoshizawa, Akihiko; Date, Hiroshi; Hirai, Toyohiro Share Save Share Save Share Save Survival impact of treatment for chronic obstructive pulmonary disease in patients with advanced non-small-cell lung cancer (Dec, 10.1038/s41598-021-03139-5, 2021)Ajimizu, Hitomi; Ozasa, Hiroaki; Sato, Susumu; Funazo, Tomoko; Sakamori, Yuichi; Nomizo, Takashi; Kuninaga, Kiyomitsu; Ogimoto, Tatsuya; Hosoya, Kazutaka; Yamazoe, Masatoshi; Tsuji, Takahiro; Yoshida, Hironori; Itotani, Ryo; Ueno, Kentaro; Kim, Young Hak; Muro, Shigeo; Hirai, Toyohiro Share Save Adaptive resistance to lorlatinib via EGFR signaling in ALK-rearranged lung cancerKatayama, Yuki; Yamada, Tadaaki; Tanimura, Keiko; Tokuda, Shinsaku; Morimoto, Kenji; Hirai, Soichi; Matsui, Yohei; Nakamura, Ryota; Ishida, Masaki; Kawachi, Hayato; Yoneda, Kazue; Hosoya, Kazutaka; Tsuji, Takahiro; Ozasa, Hiroaki; Yoshimura, Akihiro; Iwasaku, Masahiro; Kim, Young Hak; Horinaka, Mano; Sakai, Toshiyuki; Utsumi, Takahiro; Shiotsu, Shinsuke; Takeda, Takayuki; Katayama, Ryohei; Takayama, Koichi Share Save Combination bezafibrate and nivolumab treatment of patients with advanced non-small cell lung cancerTanaka, Kentaro; Chamoto, Kenji; Saeki, Sho; Hatae, Ryusuke; Ikematsu, Yuki; Sakai, Kazuko; Ando, Nobuhisa; Sonomura, Kazuhiro; Kojima, Shinsuke; Taketsuna, Masanori; Kim, Young Hak; Yoshida, Hironori; Ozasa, Hiroaki; Sakamori, Yuichi; Hirano, Tomoko; Matsuda, Fumihiko; Hirai, Toyohiro; Nishio, Kazuto; Sakagami, Takuro; Fukushima, Masanori; Nakanishi, Yoichi; Honjo, Tasuku; Okamoto, Isamu Share Save Share Save Survival impact of treatment for chronic obstructive pulmonary disease in patients with advanced non-small-cell lung cancerAjimizu, Hitomi; Ozasa, Hiroaki; Sato, Susumu; Funazo, Tomoko; Sakamori, Yuichi; Nomizo, Takashi; Kuninaga, Kiyomitsu; Ogimoto, Tatsuya; Hosoya, Kazutaka; Yamazoe, Masatoshi; Tsuji, Takahiro; Yoshida, Hironori; Itotani, Ryo; Ueno, Kentaro; Kim, Young Hak; Muro, Shigeo; Hirai, Toyohiro Share Save Share Save PD-L1 polymorphisms predict survival outcomes in advanced non-small-cell lung cancer patients treated with PD-1 blockadeYoshida, Hironori; Nomizo, Takashi; Ozasa, Hiroaki; Tsuji, Takahiro; Funazo, Tomoko; Yasuda, Yuto; Ajimizu, Hitomi; Yamazoe, Masatoshi; Kuninaga, Kiyomitsu; Ogimoto, Tatsuya; Hosoya, Kazutaka; Itotani, Ryo; Sakamori, Yuichi; Kim, Young Hak; Hirai, Toyohiro Share Save Paratracheal Middle Mediastinal Thymic CarcinomasNakanobo, Ryo; Hamaji, Masatsugu; Ohsumi, Akihiro; Koyasu, Sho; Yoshida, Hironori; Ozasa, Hiroaki; Isowa, Masahide; Nakajima, Naoki; Yoshizawa, Akihiko; Date, Hiroshi Share Save 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
